Genetron Holdings ROA 2024

Genetron Holdings Aktienanalyse

What does Genetron Holdings do?

Genetron Holdings Ltd is a Chinese company that focuses on the development of discoveries in genomic research. They are known for their advanced technologies that allow for the development of cancer diagnostics and personalized therapies. History: Genetron was founded in 2015 by Sizhen Wang, a leading expert in the field of molecular diagnostics. Since then, the company has experienced rapid growth and has become a well-known name in genomic research. In 2019, Genetron Holdings went public on the Beijing Star Board of the Chinese stock exchange. Business model and divisions: The company is divided into two main activities - diagnostics and research. In the diagnostics division, the company focuses on developing personalized medicines for cancer patients. Genetron works closely with hospitals and research institutions throughout China to develop diagnostic tools for cancer prevention. In the research department, the company is involved in the discovery of new genetic markers for various diseases. Genetron utilizes state-of-the-art technologies such as Crispr-Cas9 to edit genes and determine which genes are responsible for which diseases. Products and services: Genetron offers a range of products and services for cancer diagnostics. One of their most well-known products is the Genetron Health System, a platform for personalized medicine. The system uses genetic profiles to identify the best treatment options for patients. Genetron also offers a variety of other diagnostic tests, including tests for ovarian cancer, lung cancer, and stomach cancer. The company also offers a variety of research services. These include genetic studies, the discovery of new medical therapies, and collaboration with other companies in the field of genomic research. Conclusion: Genetron Holdings Ltd is a company with a fascinating history and a unique business model. Their dedication to innovative cancer diagnostics and personalized medicine has helped them become leaders in genomic research. The company offers a wide range of products and services and works closely with the medical community to improve the health and well-being of patients. Genetron Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Genetron Holdings's Return on Assets (ROA)

Genetron Holdings's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Genetron Holdings's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Genetron Holdings's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Genetron Holdings’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Genetron Holdings stock

What is the Return on Assets (ROA) of Genetron Holdings this year?

The Return on Assets (ROA) of Genetron Holdings is -0.83 undefined this year.

What was the ROA of Genetron Holdings compared to the previous year?

The ROA of Genetron Holdings has increased by 153.51% compared to the previous year.

What consequences do high ROA have for investors of Genetron Holdings?

A high ROA is advantageous for investors of Genetron Holdings, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Genetron Holdings?

A low ROA can be unfavorable for investors of Genetron Holdings as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Genetron Holdings affect the company?

An increase in ROA of Genetron Holdings can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Genetron Holdings impact the company?

A reduction in the ROA of Genetron Holdings can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Genetron Holdings?

Some factors that can influence the ROA of Genetron Holdings include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Genetron Holdings important for investors?

The ROA of Genetron Holdings is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Genetron Holdings take to improve ROA?

To improve ROA, Genetron Holdings can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Genetron Holdings pay?

Over the past 12 months, Genetron Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genetron Holdings is expected to pay a dividend of 0 CNY.

What is the dividend yield of Genetron Holdings?

The current dividend yield of Genetron Holdings is .

When does Genetron Holdings pay dividends?

Genetron Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Genetron Holdings?

Genetron Holdings paid dividends every year for the past 0 years.

What is the dividend of Genetron Holdings?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Genetron Holdings located?

Genetron Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Genetron Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Genetron Holdings from 9/12/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 9/12/2024.

When did Genetron Holdings pay the last dividend?

The last dividend was paid out on 9/12/2024.

What was the dividend of Genetron Holdings in the year 2023?

In the year 2023, Genetron Holdings distributed 0 CNY as dividends.

In which currency does Genetron Holdings pay out the dividend?

The dividends of Genetron Holdings are distributed in CNY.